View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Adrian Kowollik
  • Adrian Kowollik

Update on Voxel S.A.

Voxel is a leading Polish operator of diagnostic centres with mainly MRI, CT, PET and SPECT devices. Moreover, it produces radiopharmaceuticals and acts as distributor of medical devices and healthcare software (incl. AI-powered tools).

Adrian Kowollik
  • Adrian Kowollik

Update on Voxel S.A.

Voxel is a leading Polish operator of diagnostic services, producer of radiopharmaceutical and distributor of medical devices and software.

Adrian Kowollik
  • Adrian Kowollik

Update on Voxel S.A.

Voxel is a leading provider of diagnostic imaging exams (PET, MRI, CT, SPECT) in Poland. The company also produces radiopharmaceuticals and distributes medial equipment and healthcare software.

Adrian Kowollik
  • Adrian Kowollik

Update on Voxel S.A.

Voxel is a leading operator of diagnostic imaging centres in Poland. The company also distributes medical equipment and software and produces radiopharmaceutical.

Adrian Kowollik
  • Adrian Kowollik

Update on Voxel S.A.

Voxel is a leading Polish provider of diagnostic imaging services, radoopharmaceuticals, medical equipment and IT solutions.

Adrian Kowollik
  • Adrian Kowollik

Update on Voxel S.A.

Voxel is a Polish leader in diagnostic imaging. It also produces radiopharmaceuticals and distributes medical equipment and software.

Voxel S.A.: 1 director

A director at Voxel S.A. sold 2,000 shares at 52.609PLN and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

Adrian Kowollik
  • Adrian Kowollik

Update on Voxel S.A.

Voxel is a Polish leader in the area of diagnostic imaging and respective equipment.

Adrian Kowollik
  • Adrian Kowollik

Update on Voxel S.A.

Voxel is a Top 3 Polish diagnostic imaging company with own centers and cyclotrons. Moreover, the company delivers and installs hardware and software for diagnostic centres.

Adrian Kowollik
  • Adrian Kowollik

Update on the Polish healthcare sector

The reports comprises latest market information and recos for the companies ENEL-MED (market cap EUR 87.3m) Synektik (EUR 58.7m) and Voxel (EUR 98.7m).

Sylwia Jaśkiewicz
  • Sylwia Jaśkiewicz
Sylwia Jaśkiewicz
  • Sylwia Jaśkiewicz

Voxel: 2Q20 results vs forecasts; 12M EFV up to PLN 50.4

Voxel: 2Q20 results vs forecasts; 12M EFV up to PLN 50.4

Sylwia Jaśkiewicz
  • Sylwia Jaśkiewicz

Voxel: Tests for SARS-CoV-2

Voxel: Tests for SARS-CoV-2

Sylwia Jaśkiewicz
  • Sylwia Jaśkiewicz

Voxel: 2Q20 financial forecasts; Buy (from Hold), Overweight (from Neu...

Voxel: 2Q20 financial forecasts; Buy (from Hold), Overweight (from Neutral); 12M EFV at PLN 43.0

Research Team
  • Research Team

DM BOŚ: Daily research report – date 26.06.2020

Headlines Conferences calendar … 2 Large-cap companies news … 3 CCC: Strategy update/ Sustainability strategy LPP: The Company’s management outlook; possible significant write-offs in 2Q20/21 CD Projekt: Positive previews after hands-on events. CD Projekt: Nigt City Wire: new trailer, new mechanic, Netflix show announced. PGNiG, PKN Orlen: Extension of gas contract PKN Orlen: Orlen China to be created in 2H20 Eurocash: Frisco purchase finalized PGE: 100 MW new windfarm launched Teleco...

Sylwia Jaśkiewicz
  • Sylwia Jaśkiewicz

Voxel: 1Q20 financials vs. forecasts

On June 25, after the market close, the Company revealed its 1Q20 financial results which exhibit a huge impact of the COVID-19 pandemic, albeit the reported operating results are better than our expectations (PLN 6.7 million of gain on the bargain purchase of Scanix). Nevertheless while adjusted they underperformed. Accordingly, we downgrade both our LT fundamental Buy recommendation and ST relative Overweight rating for the Company to Hold and Neutral, respectively, and remove Voxel’s shares ...

Research Team
  • Research Team

Polish Equities Monthly: July 2020 Worlds apart

Polish Equities Monthly: July 2020 Worlds apart Nasdaq Composite at its all-time high (and +11.7% ytd) and S&P500 a tad in the positive territory from the ytd RoR perspective – that was the world of the stock market just a few days ago. It hardly reconciled not only with realistic, in our view, scenarios for the economic recovery (discussed in our previous Monthly research report, 6/2020/MR(59), dated May 19), but also with the mathematics of changes in the U.S. earnings expectations (the abru...

Research Team
  • Research Team

DM BOŚ: Daily research report – date 24.03.2020

Headlines Large-cap companies news Asseco Poland: (i) 4Q19 results released – no surprises (strong subs, weak parent), (ii) backlog (strong), (iii) dividend proposal (tad lower yoy) KGHM: Production and sale volumes for February CCC: Postponement of debt payment; suspension of factoring payment Tauron: Planned joint investments with PFR in renewables projects Telecommunications services: 5G tender on track Banks: Watchdog urges for more leeway in assessing the impact of the pandemic on re...

Sylwia Jaśkiewicz
  • Sylwia Jaśkiewicz

Voxel

4Q19 financial results On March 22, after the market close, Voxel released its 4Q19 financial results which are quite in line with our expectations as far as EBITDA is concerned, though slightly lower as regards NI mainly due to a one-off (PLN 0.5 million) and higher financial costs than we assumed (one-time valuation/a writeoff for loans and receivables in the amount of PLN 1.1 million).

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch